EnglishEnglish
IF 15.1 Self-stabilizing monodisperse nanoMOFs for controlled enzyme delivery
You are here: Home » BK Academic Frontier » Biomaterials Frontier » IF 15.1 Self-stabilizing monodisperse nanoMOFs for controlled enzyme delivery

IF 15.1 Self-stabilizing monodisperse nanoMOFs for controlled enzyme delivery

Inquire

Controlled loading of multiple active species on metal-organic frameworks (MOFs) and maintaining monodispersity has long been a huge challenge because MOFs are prone to agglomeration and collapse in water. Here, we develop an emerging self-stable dual-enzyme delivery system with long-lasting monodispersity that enables synergistic cancer starvation and photothermal therapy (PTT) without any chemotherapy. The loading of glucose oxidase (GOx) confers a strong coordination interaction with the MOF, which not only confers strong self-stabilizing monodispersity without any surface modification, but also guarantees catalytic and photothermal conversion properties Uniform deposition of Au nanoparticles and GOx-like nanozymes. Our design establishes an effective synergistic therapeutic platform to generate reactive oxygen species, reduce mitochondrial membrane potential, and induce apoptosis. Immunofluorescence studies confirmed that Caspase 3 protein activated the apoptosis pathway and significantly inhibited the proliferation of cancer cells. Our work provides new insights into stabilizing MOFs by GOx without any chemical modification and constructs an unprecedented dual-enzyme delivery system with excellent cancer synergy at very low doses without using any chemotherapeutic drugs. treatment effect.

企业微信截图_20240718090159.png 718 901

Beike Nano Technology Co., Ltd. was established in 2015, is a professional nano medical Contract Research Organization (CRO) in China.

Quick Line

Product Category

Contact
Copyright © 2023 Beike Nano Technology Co., Ltd. All Rights Reserved. Support by Leadong Sitemap. Privacy Policy  Shipping Policy  Return& Refund Policy